Gene · 8243
Papers2,883
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 2,883
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Non-canonical role of wild-type SEC23B in the cellular stress response pathway. | Cell Death Dis | 2021 | 33753724 | PubTator, text mining | PubMed |
| Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1. | NPJ Precis Oncol | 2021 | 33742100 | PubTator, text mining | PubMed |
| Immunoinformatics Design of Multi-Epitope Peptide-Based Vaccine Against Schistosoma mansoni Using Transmembrane Proteins as a Target. | Front Immunol | 2021 | 33737928 | PubTator, text mining | PubMed |
| Versatile Labeling and Detection of Endogenous Proteins Using Tag-Assisted Split Enzyme Complementation. | ACS Chem Biol | 2021 | 33734687 | PubTator, text mining | PubMed |
| ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | Hum Mol Genet | 2021 | 33729478 | PubTator, text mining | PubMed |
| Balancing cohesin eviction and retention prevents aberrant chromosomal interactions, Polycomb-mediated repression, and X-inactivation. | Mol Cell | 2021 | 33725485 | PubTator, text mining | PubMed |
| Functional impact of cancer-associated cohesin variants on gene expression and cellular identity. | Genetics | 2021 | 33704438 | PubTator, text mining | PubMed |
| AKT-dependent signaling of extracellular cues through telomeres impact on tumorigenesis. | PLoS Genet | 2021 | 33690611 | PubTator, text mining | PubMed |
| The CD44high Subpopulation of Multifraction Irradiation-Surviving NSCLC Cells Exhibits Partial EMT-Program Activation and DNA Damage Response Depending on Their p53 Status. | Int J Mol Sci | 2021 | 33673439 | PubTator, text mining | PubMed |
| Role of the DDX11 DNA Helicase in Warsaw Breakage Syndrome Etiology. | Int J Mol Sci | 2021 | 33669056 | PubTator, text mining | PubMed |
| Molecular Targeted Therapy in Myelodysplastic Syndromes: New Options for Tailored Treatments. | Cancers (Basel) | 2021 | 33668555 | PubTator, text mining | PubMed |
| FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2. | Mol Cancer | 2021 | 33658012 | PubTator, text mining | PubMed |
| Label-free proteomics uncovers SMC1A expression is Down-regulated in AUB-E. | Reprod Biol Endocrinol | 2021 | 33653363 | PubTator, text mining | PubMed |
| Splicing factors control triple-negative breast cancer cell mitosis through SUN2 interaction and sororin intron retention. | J Exp Clin Cancer Res | 2021 | 33648524 | PubTator, text mining | PubMed |
| Signaling-to-chromatin pathways in the immune system. | Immunol Rev | 2021 | 33644906 | PubTator, text mining | PubMed |
| Whole Exome Sequencing Identifies Cohesin Component STAG1 Mutation in de novo Acute Myeloid Leukemia (FAB M2): A Pilot Study with Cytogenetics, Clinical and Prognostic Implications. | J Environ Pathol Toxicol Oncol | 2021 | 33639073 | PubTator, text mining | PubMed |
| Case Report: Prenatal Whole-Exome Sequencing to Identify a Novel Heterozygous Synonymous Variant in NIPBL in a Fetus With Cornelia de Lange Syndrome. | Front Genet | 2021 | 33633789 | PubTator, text mining | PubMed |
| PD-L1 regulates genomic stability via interaction with cohesin-SA1 in the nucleus. | Signal Transduct Target Ther | 2021 | 33627620 | PubTator, text mining | PubMed |
| The deacetylation-phosphorylation regulation of SIRT2-SMC1A axis as a mechanism of antimitotic catastrophe in early tumorigenesis. | Sci Adv | 2021 | 33627431 | PubTator, text mining | PubMed |
| A cohesive look at leukemogenesis: The cohesin complex and other driving mutations in AML. | Neoplasia | 2021 | 33621854 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8243/papers?page=45